IPO - Salarius Pharmaceuticals, Inc.

Form Type: S-1

Filing Date: 2025-01-21

Corporate Action: Ipo

Type: New

Accession Number: 000162828025001947

Filing Summary: Salarius Pharmaceuticals, Inc. is filing a registration statement on Form S-1 for a public offering of shares of its common stock and pre-funded warrants. The common stock has a par value of $0.0001, and the offering is initiated to allow certain purchasers, whose acquisition could result in them owning more than 4.99% of Salarius' outstanding common stock, to purchase pre-funded warrants instead of shares. Each pre-funded warrant is exercisable for one share of common stock. The underwriters have an option to purchase additional shares of common stock to cover over-allotments for 45 days post-offering. Salarius is categorized as a smaller reporting company and intends to comply with reduced public company reporting requirements. Furthermore, the company warns investors about the risks associated with the investment, highlighting the high degree of risk involved in investing in its securities. The anticipated date for selling to the public is expected to be as soon as practicable after the effectiveness of the registration statement, and the final public offering price will be negotiated based on several factors including market conditions and the company’s prospects. Salarius’ common stock is listed on The Nasdaq Capital Market under the symbol 'SLRX'.

Document Link: View Document